COSCIENS Biopharma Total Liabilities

COSCIENS Biopharma posts a total liabilities of $20M as of June 2025. That compares with $24M in the prior-year period — down 14.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, COSCIENS Biopharma's total liabilities was $24M. The latest reading is $20M — a 14.1% year-over-year decrease (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of COSCIENS Biopharma's financial statement story. At $20M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CSCI's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; COSCIENS Biopharma's other metric pages and overview cover the third.